🇺🇸 FDA
Patent

US 7368463

Substituted 4-amino-1-benzylpiperidine compounds

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7368463 (Substituted 4-amino-1-benzylpiperidine compounds) held by Theravance, Inc. expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P13/00